About this episode
繼二十多年前輝瑞藥廠推出威而鋼、拯救整家公司並發展出一個全新領域，近來又有一款新藥紅遍全球而且規模將數倍於威而鋼，目前讓兩家藥廠爆衝：諾和諾德( Novo Nordisk)和禮萊(Eli Lily)。
原本是治療高血壓和高血糖，意外發現有瘦身功效，進而成為各個科別醫師都在開的治療處方，這一切是如何發生？那些人群適合而哪些應該避開？
專長在肥胖和睡眠問題的劉才睿醫師，特別從肥胖和相關慢性病的治療經驗分析，這一波瘦身藥的熱潮背後和藥廠下一步。
--
歡迎訂閱數位時代YouTube https://www.youtube.com/@bnext_official
有合作需求請洽：[email protected]
Powered by Firstory Hosting
Get every episode summarized
Each time 數位時代 Business Next publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from 數位時代 Business Next
EP308. 兩家搶著綁椿聯發科，輝達 vs. Google誰是AI新霸主？ ft.科技專家吳金榮
數位時代 Business Next
Sep 9, 202652:38skipped_language
記者茶水間235.SK海力士如何從「慘業」翻身？AI讓記憶體變印鈔機，中韓大戰下一步打到哪？
數位時代 Business Next
Sep 7, 202619:32pending
東京在線EP40_ 終生雇用即將消失？聘雇日本人才前你一定得知道的人事雇用新趨勢！
數位時代 Business Next
Sep 7, 202622:19skipped_language
數位關鍵字256.Claude 怎麼讓看不見的記號埋進文字？IBM 首席科學家陳品諭拆解 AI 浮水印
數位時代 Business Next
Sep 4, 20261:06:37skipped_language